Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 8,042 shares at $16.80 ($135K) on 2023-01-11, disclosed to the SEC on 2023-01-13.
Open-market sale of $135k IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.80 | 4,021 | $68K | 50.0% |
| 2 | $16.80 | 4,021 | $68K | 50.0% |
| Total | $16.80 avg | 8,042 | $135K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |